Enterprise Value
-16.78M
Cash
38.47M
Avg Qtr Burn
-19.27M
Short % of Float
14.19%
Insider Ownership
0.73%
Institutional Own.
0.01%
Qtr Updated
12/31/21
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
KB195 Details UCD (Urea Cycle Disorders) | Failed Discontinued | |
KB295 Details Inflammatory bowel disease | Failed Discontinued | |
KB109 Details Chronic obstructive pulmonary disease | Failed Discontinued |